Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07732361

A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).

Sponsor: Alexion Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study was to assess OS outcomes in pediatric (≥ 28 days of age at the time of HSCT-TMA diagnosis) and adult participants diagnosed with HSCT-TMA(referred to as TMA from hereon) within 52 weeks after HSCT and who were either complement inhibitor treatment naïve or had been treated with eculizumab.

Official title: A Secondary Real-world Data Study of Pediatric and Adult Participants With Thrombotic Microangiopathy (TMA) After Hematopoietic Stem Cell Transplant (HSCT)

Key Details

Gender

All

Age Range

4 Weeks - Any

Study Type

OBSERVATIONAL

Enrollment

307

Start Date

2025-01-22

Completion Date

2026-03-31

Last Updated

2026-07-28

Healthy Volunteers

No

Locations (43)

Research Facility

Boston, Massachusetts, United States

Research Facility

Akron, Ohio, United States

Research Facility

Salt Lake City, Utah, United States

Research Facility

Brussels, Brussels Capital, Belgium

Research Facility

Liège, Belgium

Research Facility

Fortaleza, Ceará, Brazil

Research Facility

Brasília, Federal District, Brazil

Research Facility

Curitiba, Paraná, Brazil

Research Facility

Recife, Pernambuco, Brazil

Research Facility

Porto Alegre, Rio Grande do Sul, Brazil

Research Facility

Jaú, São Paulo, Brazil

Research Facility

Rio de Janeiro, Brazil

Research Facility

São Paulo, Brazil

Research Facility

São Paulo, Brazil

Research Facility

São Paulo, Brazil

Research Facility

São Paulo, Brazil

Research Facility

Pessac, Gironde, France

Research Facility

Toulouse, Haute Garonne, France

Research Facility

Grenoble, Isere, France

Research Facility

Paris, France

Research Facility

Thessaloniki, Central Macedonia, Greece

Research Facility

Pátrai, West Greece, Greece

Research Facility

Rome, Lazio, Italy

Research Facility

Ancona, Italy

Research Facility

Brescia, Italy

Research Facility

Florence, Italy

Research Facility

Genova, Italy

Research Facility

Naples, Italy

Research Facility

Pavia, Italy

Research Facility

Roma, Italy

Research Facility

Torino, Italy

Research Facility

Fukushima, Fukushima, Japan

Research Facility

Tsukuba, Ibaraki, Japan

Research Facility

Saitama-shi, Saitama, Japan

Research Facility

Wakayama, Wakayama, Japan

Research Facility

Seoul, South Korea

Research Facility

Seoul, South Korea

Research Facility

Seoul, South Korea

Research Facility

Barcelona, Spain

Research Facility

Barcelona, Spain

Research Facility

London, Greater London, United Kingdom

Research Facility

Newcastle, Tyne & Wear, United Kingdom

Research Facility

Birmingham, West Midlands, United Kingdom